Technical Note: MRI-guided breast biopsy - our preliminary experience

Autor: Taneja Sangeeta, Jena Amarnath, Kumar Kapil, Mehta Anurag

Publikováno v: Indian Journal of Radiology and Imaging, Vol 20, Iss 3, Pp 218-220 (2010)

The diagnostic potential of breast MRI can be fully utilized only when it is possible to biopsy lesions detected on MRI, especially when they are not visible on mammography or USG. We would like to describe our experience with MRI-guided wire localiz

Externí odkaz: https://doaj.org/article/9ca14341aeb6471fa74764d7835862d4

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

Autor: Patil V; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Noronha V; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Dhumal SB; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Joshi A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Menon N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Bhattacharjee A; Section of Biostatistics, Centre for Cancer Epidemiology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Kulkarni S; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Ankathi SK; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Mahajan A; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Sable N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Nawale K; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Bhelekar A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Mukadam S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Chandrasekharan A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Das S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Vallathol D; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., D'Souza H; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Kumar A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Agrawal A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Khaddar S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Rathnasamy N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Shenoy R; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Kashyap L; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Rai RK; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Abraham G; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Saha S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Majumdar S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Karuvandan N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Simha V; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Babu V; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Elamarthi P; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Rajpurohit A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Kumar KAP; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Srikanth A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Ravind R; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Banavali S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India., Prabhash K; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India. Electronic address: id-kumarprabhashtmh@gmail.com.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2020 Sep; Vol. 8 (9), pp. e1213-e1222.